Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
A SPAC I Acquisition Unit | ASCAU | May 15, 2024 | 2.96 | 0.00 |
A SPAC II Acquisition | ASCB | May 15, 2024 | 11.12 | 0.00 |
A-Mark Precious Metals | AMRK | May 15, 2024 | 37.30 | -6.28 |
a.k.a Brands | AKA | May 15, 2024 | 29.50 | +1.72 |
A.O Smith | AOS | May 15, 2024 | 86.77 | +0.43 |
A10 Networks | ATEN | May 15, 2024 | 15.86 | +0.57 |
A2Z Smart Technologies | AZ | May 15, 2024 | 0.44 | +6.29 |
AAA - A Rated Corporate Bond Ishares | QLTA | May 15, 2024 | 47.05 | +0.72 |
Aadi Bioscience | AADI | May 15, 2024 | 1.84 | -2.13 |
AAON | AAON | May 15, 2024 | 75.82 | +0.56 |
AAR | AIR | May 15, 2024 | 71.95 | -0.21 |
Abacus Life | ABL | May 15, 2024 | 11.97 | +2.48 |
Abbott Laboratories | ABT | May 15, 2024 | 104.59 | +0.56 |
AbbVie | ABBV | May 15, 2024 | 163.79 | +1.36 |
AbCellera Biologics | ABCL | May 15, 2024 | 3.70 | -3.14 |
Abeona Therapeutics | ABEO | May 15, 2024 | 4.71 | +12.14 |
Abercrombie & Fitch | ANF | May 15, 2024 | 137.68 | +1.01 |
Aberdeen Asia-Pacificome Fund | FAX | May 15, 2024 | 2.65 | +1.92 |
Aberdeen Australia Equity Fund | IAF | May 15, 2024 | 4.47 | +0.90 |
Aberdeen Emerging Markets Fund | AEF | May 15, 2024 | 5.32 | +0.85 |
Aberdeen Global Fund | FCO | May 15, 2024 | 5.93 | +1.54 |
Aberdeen Global Infrastructure | ASGI | May 15, 2024 | 18.79 | -1.11 |
Aberdeen Income Credit Strategies Fund | ACP | May 15, 2024 | 6.92 | +1.02 |
Aberdeen Income Credit Strategies Pref | ACP-A | May 15, 2024 | 24.85 | +2.01 |
Aberdeen Japan Equity Fund | JEQ | May 15, 2024 | 6.03 | +0.33 |
Abits Group | ABTS | May 15, 2024 | 0.68 | -6.37 |
Abivax SA - American Depositary Shares | ABVX | May 15, 2024 | 13.95 | +0.72 |
Able View Global | ABLV | May 15, 2024 | 1.67 | +7.74 |
ABM Industries | ABM | May 15, 2024 | 46.02 | +0.15 |
Abrdn Global Dynamic Dividend Fund | AGD | May 15, 2024 | 9.79 | +1.03 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.